Home LiteratureArticle Details
PMID: 16740706 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors.

Cancer research ·Vol. 66 ·No. 11 ·2006-06-01 ·Pages 5686-95

Krneta J, Kroll J, Alves F, Prahst C, Sananbenesi F, Dullin C, Kimmina S, Phillips DJ, Augustin HG

Abstract

The transforming growth factor-beta superfamily member activin and its antagonist, follistatin, act as a pleiotropic growth factor system that controls cell proliferation, differentiation, and apoptosis. Activin inhibits fibroblast growth factor 2-induced sprouting angiogenesis in vitro (spheroidal angiogenesis assay) and in vivo (Matrigel assay). To further study the role of the activin/follistatin system during angiogenesis and tumor progression, activin- and follistatin-expressing R30C mammary carcinoma cells were studied in mouse tumor experiments. Surprisingly, activin-expressing tumors grew much faster than follistatin-expressing tumors although they failed to induce increased angiogenesis (as evidenced by low microvessel density counts). Conversely, follistatin-expressing tumors were much smaller but had a dense network of small-diameter capillaries. Qualitative angioarchitectural analyses (mural cell recruitment, perfusion) revealed no major functional differences of the tumor neovasculature. Analysis of activin- and follistatin-expressing R30C cells identified a cell autonomous role of this system in controlling tumor cell growth. Whereas proliferation of R30C cells was not altered, follistatin-expressing R30C cells had an enhanced susceptibility to undergo apoptosis. These findings in experimental tumors are complemented by an intriguing case report of a human renal cell carcinoma that similarly shows a dissociation of angiogenesis and tumorigenesis during tumor progression. Collectively, the data shed further light into the dichotomous stimulating and inhibiting roles that the activin/follistatin system can exert during angiogenesis and tumor progression. Furthermore, the experiments provide a critical proof-of-principle example for the dissociation of angiogenesis and tumorigenesis, supporting the concept that tumor growth may not be dependent on increased angiogenesis as long as a minimal intratumoral microvessel density is maintained.

MeSH Terms
Activins/biosynthesis,genetics Animals Apoptosis/physiology Breast Neoplasms/blood supply,genetics,metabolism,pathology Carcinoma, Renal Cell/blood supply,metabolism,pathology Cell Cycle/physiology Cell Growth Processes/physiology Cell Line, Tumor Follistatin/biosynthesis,genetics Humans Kidney Neoplasms/blood supply,metabolism,pathology Mice Mice, Nude Mice, SCID Neoplasm Transplantation Neovascularization, Pathologic/metabolism Transfection Transplantation, Heterologous
Chemicals
Follistatin Activins
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Krneta Jelena
Department of Vascular Biology and Angiogenesis Research, Tumor Biology Center Freiburg, Freiburg, Germany.
Kroll Jens
Alves Frauke
Prahst Claudia
Sananbenesi Farahnaz
Dullin Christian
Kimmina Sarah
Phillips David J
Augustin Hellmut G
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
2006-06-01
Pages
5686-95
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]